Physician profile
Stuart Mishelof
NPI 1821300534
$6,182.65
in general payments reported to CMS, 2019-2025
32 companies · $1,383 in 2025
The $1,383 reported for 2025 was more than what 86% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,067 · 2022: $1,419 · 2023: $906 · 2024: $1,408 · 2025: $1,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,696.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,980.65 | 2021-2025 | |
| Amgen INC. | $402.53 | 2021-2025 | Evenity, Prolia, Repatha |
| Daiichi Sankyo INC. | $349.51 | 2021-2025 | Injectafer |
| Pfizer INC. | $298.05 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $260.57 | 2021-2023 | Belsomra, Gardasil 9, Pneumovax 23 |
| Lilly USA, LLC | $211.10 | 2021-2025 | Jardiance, Mounjaro, Emgality |
| Astrazeneca Pharmaceuticals LP | $205.56 | 2021-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $190.66 | 2021-2025 | Ozempic, Rybelsus |
| Dexcom, INC. | $150.66 | 2024-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $141.71 | 2022-2024 | Proclaim, Freestyle Libre 2, Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $123.13 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.29 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.92 | 2021-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.40 | 2021-2025 | Xifaxan |
| Mylan Specialty L.P. | $73.18 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $53.52 | 2023-2024 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $46.00 | 2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $45.07 | 2022 | |
| Sumitomo Pharma America, INC. | $42.06 | 2023-2025 | Gemtesa |
| Sanofi Pasteur INC. | $37.86 | 2023-2024 | |
| Biohaven Pharmaceuticals, INC. | $35.32 | 2021 | |
| Idorsia Pharmaceuticals US INC | $30.24 | 2023 | Quviviq |
| Vertex Pharmaceuticals Incorporated | $27.29 | 2025 | |
| Verity Pharmaceuticals INC. | $22.62 | 2025 | Tlando |
| Janssen Pharmaceuticals, INC | $22.11 | 2022 | |
| Astellas Pharma US INC | $21.70 | 2025 | Veozah |
| Glaxosmithkline, LLC. | $20.69 | 2024 | Arexvy, Shingrix |
| Arbor Pharmaceuticals, INC. | $19.37 | 2021 | |
| Sanofi-Aventis U.S. LLC | $19.00 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $18.34 | 2021 | |
| Tandem Diabetes Care, INC. | $14.80 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amarin Pharma, INC. | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Mishelof listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.